Publication | Closed Access

A New Insulin Immunoassay Specific for the Rapid-Acting Insulin Analog, Insulin Aspart, Suitable for Bioavailability, Bioequivalence, and Pharmacokinetic Studies

Pharmacokinetic StudiesTranslational MedicineDiabetes ManagementMedicineRapid-acting Insulin AnalogDiabetesImmunologyInsulin ManagementInsulin DeliveryPharmacologyInsulin AspartInsulin Signaling